Clinical and Translational Gastroenterology

Clinical and Translational Gastroenterology is an open-access online journal covering clinical and translational gastroenterology and hepatology, published by Wolters Kluwer on behalf of the American College of Gastroenterology and established in 2010, with a 2024 impact factor of 3.0（Clinical and Translational Gastroenterology）是由（Wolters Kluwer）代表（American College of Gastroenterology）出版的开放获取在线期刊，专注临床与转化胃肠病学及肝病学，创刊于 2010 年，2024 年影响因子为 3.0。

Scope

• Innovative clinical research in gastroenterology and hepatology胃肠病学与肝病学领域的创新性临床研究。
• Novel cohort studies and case series新颖的队列研究与病例系列。
• Early-phase clinical trials早期临床试验。
• Qualitative and quantitative epidemiologic research and hypothesis-generating studies定性与定量流行病学研究以及产生假说的研究。
• Studies of novel mechanisms and methodologies, including public health interventions, and integration of approaches across organs and disciplines新机制与新方法学研究，包括公共卫生干预，以及跨器官与跨学科的整合研究。

History

• The journal was established in 2010, with David C. Whitcomb as its inaugural editor-in-chief该刊创刊于 2010 年，首任主编为 David C. Whitcomb。
• It was first published by Nature Publishing Group before moving to Wolters Kluwer Health该刊最初由（Nature Publishing Group）出版，后转由（Wolters Kluwer Health）出版。
• It received its first impact factor, 3.472, in 2015, making it the top-ranked open-access journal in gastroenterology and hepatology at the time该刊于 2015 年获得首个影响因子 3.472，当时是胃肠病学与肝病学领域排名第一的开放获取期刊。
• It is issued monthly and is the sister journal to The American Journal of Gastroenterology该刊按月出版，是（The American Journal of Gastroenterology）的姊妹刊。

Editors

• The editor-in-chief is Brian C. Jacobson of Boston University, who took over in March 2021现任主编为（Boston University）的 Brian C. Jacobson，于 2021 年 3 月接任。
• In January 2022, the journal moved to a double-blind peer review process, having previously used single-blind review该刊自 2022 年 1 月起改用双盲同行评审，此前采用单盲评审。
• An editorial board and associate editors drawn from the clinical and translational gastroenterology community manage submissions来自临床与转化胃肠病学界的编委会与副编辑团队负责稿件处理。
• Manuscripts are submitted through Editorial Manager and, under double-blind review, identifying information is removed so that both authors and reviewers remain anonymous稿件经由（Editorial Manager）投稿，在双盲评审下隐去身份信息，使作者与评审人互不知晓。